SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novartis trial suspensions seen as limited financial impact

Citi analysts said Novartis’s decision to suspend several cell-therapy clinical trials after three patient deaths is expected to have limited financial impact, pending further updates.

NOT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories